Aapro, Matti
Krendyukov, Andriy
Schiestl, Martin
Gascón, Pere
Funding for this research was provided by:
Sandoz/Hexal AG
Article History
First Online: 7 February 2018
Change Date: 28 February 2018
Change Type: Correction
Change Details: Figure 1, HX575 column, 5th box down, which previously read “SC HX575 vs. EprexSuperscript removed/ErypoSuperscript removed 417 patients with CKD-related anemia” as shown here,
Compliance with Ethical Standards
:
: MA and PG have acted as advisors to Sandoz. MS and AK are employees of Sandoz/Hexal AG.
: Medical writing support was funded by Sandoz/Hexal AG.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with human participants or animals performed by any of the authors.